Closed Loop Medicine is focused on care pathways, outcomes and the provision of dynamic personalised regimens. We combine proven drugs with digital therapeutics enabling the digitisation and data capture of an entire care continuum.
We are working with and developing known drugs that require optimisation to improve efficacy and outcome.
The digital system performs the functions of patient guide, data collection, digital therapy delivery vehicle and compliance optimiser
Our approach integrates devices to enable real time quantitive input of data to improve patient regimen management
Are you a Payor, Provider or Life Science Company looking for more information? Find out how we can help.
Closed Loop Medicine was founded with investment from the Cambridge Angels, including some of the most successful Cambridge entrepreneurs in the drug and digital arena. After successful completion of key development milestones, institutional investment was secured from both Longwall Ventures and IQ Capital.
CLM has been founded by some of the UK’s most experienced healthcare professionals with the right vision and ambition to succeed in the new world of convergent technology.
Dr Andy Richards CBE
Dr Hakim Yadi OBE
Chief Executive Officer & Co-Founder
Dr Paul Goldsmith
Chief Innovation Officer, President & Co-Founder
Dr David Cox
Chief Digital Officer & Co-Founder
Dr Felicity Sartain
Chief Operations Officer & Co-Founder
For Payors & Providers and Life Science Companies
The ability to capture real world patient data across a care pathway, combined with a closed loop management system enables precision care for each patient whilst supporting health outcomes-based reimbursement at a population scale. CLM is actively seeking co-development partnerships with payors, providers and Life Science companies.